GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » Scaled Net Operating Assets

Mangalam Drugs & Organics (BOM:532637) Scaled Net Operating Assets : N/A (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Mangalam Drugs & Organics's operating assets for the quarter that ended in Sep. 2024 was ₹3,476 Mil. Mangalam Drugs & Organics's operating liabilities for the quarter that ended in Sep. 2024 was ₹1,331 Mil. Mangalam Drugs & Organics's Total Assets for the quarter that ended in Jun. 2024 was ₹0 Mil. Therefore, Mangalam Drugs & Organics's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was N/A.


Mangalam Drugs & Organics Scaled Net Operating Assets Historical Data

The historical data trend for Mangalam Drugs & Organics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics Scaled Net Operating Assets Chart

Mangalam Drugs & Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.73 0.87 0.90 0.72 0.67

Mangalam Drugs & Organics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mangalam Drugs & Organics's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mangalam Drugs & Organics's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Mangalam Drugs & Organics's Scaled Net Operating Assets falls into.



Mangalam Drugs & Organics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Mangalam Drugs & Organics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2024 )
=(Operating Assets (A: Mar. 2024 )-Operating Liabilities (A: Mar. 2024 ))/Total Assets (A: Mar. 2023 )
=(3325.128-909.157)/3596.288
=0.67

where

Operating Assets(A: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3337 - 11.872
=3325.128

Operating Liabilities(A: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1979.07 - 184.879 - 885.034
=909.157

Mangalam Drugs & Organics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(3475.89-1331.405)/0
=N/A

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3641.107 - 165.217
=3475.89

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2161.421 - 122.947 - 707.069
=1331.405

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mangalam Drugs & Organics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Mangalam Drugs & Organics Business Description

Traded in Other Exchanges
Address
P. D'Mello Road, Rupam Building, 3rd Floor, No. 239, Near General Post Office, Mumbai, MH, IND, 400001
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. The company is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise sales in the Indian and overseas markets. The single operating segment of the company is the Manufacturing of Bulk Drugs.

Mangalam Drugs & Organics Headlines

No Headlines